Last updated on November 2019
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Brief description of study
The purpose of this extension trial is to evaluate the long-term safety of tralokinumab.
Clinical Study Identifier: NCT03587805
